Haldosén L[au] - Search Results

Year	Number of Results
1985	1
1987	1
1988	2
1989	2
1990	3
1995	2
1996	2
1997	3
1998	3
1999	1
2000	1
2001	1
2002	4
2003	2
2004	2
2005	2
2006	3
2007	1
2008	4
2009	3
2010	1
2011	1
2012	1
2013	2
2014	1
2015	1
2016	1
2017	1
2018	2
2019	2
2021	1
2022	2
2023	0

1

Estrogen receptor beta in breast cancer.

Haldosén LA, Zhao C, Dahlman-Wright K. Haldosén LA, et al. Mol Cell Endocrinol. 2014 Jan 25;382(1):665-672. doi: 10.1016/j.mce.2013.08.005. Epub 2013 Aug 15. Mol Cell Endocrinol. 2014. PMID: 23954741 Free article. Review.

2

Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor.

Song D, He H, Sinha I, Hases L, Yan F, Archer A, Haldosen LA, Zhao C, Williams C. Song D, et al. Among authors: haldosen la. Cancer Lett. 2021 May 28;506:23-34. doi: 10.1016/j.canlet.2021.02.018. Epub 2021 Feb 27. Cancer Lett. 2021. PMID: 33652085 Free article.

3

Growth Differentiation Factor 7 promotes multiple-lineage differentiation in tenogenic cultures of mesenchymal stem cells.

Kumlin M, Lindberg K, Haldosen LA, Felländer-Tsai L, Li Y. Kumlin M, et al. Among authors: haldosen la. Injury. 2022 Dec;53(12):4165-4168. doi: 10.1016/j.injury.2022.09.017. Epub 2022 Sep 17. Injury. 2022. PMID: 36261312

4

ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions.

Song D, He H, Indukuri R, Huang Z, Stepanauskaite L, Sinha I, Haldosén LA, Zhao C, Williams C. Song D, et al. Among authors: haldosen la. Front Endocrinol (Lausanne). 2022 Jul 6;13:930227. doi: 10.3389/fendo.2022.930227. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35872983 Free PMC article.

5

Reflections on the discovery and significance of estrogen receptor beta.

Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA. Koehler KF, et al. Among authors: haldosen la. Endocr Rev. 2005 May;26(3):465-78. doi: 10.1210/er.2004-0027. Epub 2005 Apr 27. Endocr Rev. 2005. PMID: 15857973 Review.

6

Editor's Note: Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

Jia M, Andreassen T, Jensen L, Bathen TF, Sinha I, Gao H, Zhao C, Haldosen LA, Cao Y, Girnita L, Moestue SA, Dahlman-Wright K. Jia M, et al. Among authors: haldosen la. Cancer Res. 2019 Oct 15;79(20):5458. doi: 10.1158/0008-5472.CAN-19-2632. Cancer Res. 2019. PMID: 31615812 No abstract available.

7

Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

Jia M, Andreassen T, Jensen L, Bathen TF, Sinha I, Gao H, Zhao C, Haldosen LA, Cao Y, Girnita L, Moestue SA, Dahlman-Wright K. Jia M, et al. Among authors: haldosen la. Cancer Res. 2016 Oct 1;76(19):5634-5646. doi: 10.1158/0008-5472.CAN-15-2910. Epub 2016 Jul 25. Cancer Res. 2016. PMID: 27457520

8

Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1.

He H, Song D, Sinha I, Hessling B, Li X, Haldosen LA, Zhao C. He H, et al. Among authors: haldosen la. Oncogene. 2019 Jul;38(28):5725-5738. doi: 10.1038/s41388-019-0824-4. Epub 2019 Apr 23. Oncogene. 2019. PMID: 31015574

9

c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer.

He H, Sinha I, Fan R, Haldosen LA, Yan F, Zhao C, Dahlman-Wright K. He H, et al. Among authors: haldosen la. Oncogene. 2018 May;37(19):2586-2600. doi: 10.1038/s41388-018-0165-8. Epub 2018 Feb 22. Oncogene. 2018. PMID: 29467493

10

Expression of the three components of linear ubiquitin assembly complex in breast cancer.

Kharman-Biz A, Gao H, Ghiasvand R, Haldosen LA, Zendehdel K. Kharman-Biz A, et al. Among authors: haldosen la. PLoS One. 2018 May 15;13(5):e0197183. doi: 10.1371/journal.pone.0197183. eCollection 2018. PLoS One. 2018. PMID: 29763465 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results